share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Feb 27 00:16
Summary by Futu AI
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 354 shares of common stock on 02/26/2024, as per the latest filing. The shares, valued at an aggregate market value of $150,697.80, were acquired on 02/24/2024 through restricted stock vesting and performance shares as part of compensation from the issuer. This transaction follows a series of sales over the past three months, where Tatsis sold a total of 1,154 shares for gross proceeds of $485,771.76.
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 354 shares of common stock on 02/26/2024, as per the latest filing. The shares, valued at an aggregate market value of $150,697.80, were acquired on 02/24/2024 through restricted stock vesting and performance shares as part of compensation from the issuer. This transaction follows a series of sales over the past three months, where Tatsis sold a total of 1,154 shares for gross proceeds of $485,771.76.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.